PERK inhibition mitigates restenosis and thrombosis - a potential low-thrombogenic anti-restenotic paradigmBowen Wang(Northwestern University), K. Craig Kent(University of Virginia)bioRxiv (Cold Spring Harbor Laboratory)March 18, 201910.1101/581397Cited by 4SaveCiteExport RISWatch citationsRelated PapersTargeted PERK inhibition with biomimetic nanoclusters confers preventative and interventional benefits to elastase-induced abdominal aortic aneurysms|Bioactive Materials|2023|17The role of 6-phosphogluconate dehydrogenase in vascular smooth muscle cell phenotypic switching and angioplasty-induced intimal hyperplasia|JVS Vascular Science|2024|1